# c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation

**Authors:** Jing Wang, Liyuan Zhang, Keke Chen, Fangze Wei, Wendi Li, Chanjuan Cui, Feng Chen, Bing Wei, Tao Huang, Hezhi Fang, Wei Cui

PMC · DOI: 10.1038/s41419-026-08439-0 · 2026-02-05

## TL;DR

This study shows how the c-Myc/GRPEL1 pathway supports pancreatic cancer cell growth by promoting fatty acid synthesis.

## Contribution

The study identifies a novel mechanism linking mitochondrial protein quality control to fatty acid synthesis in pancreatic cancer.

## Key findings

- c-Myc promotes PDAC cell proliferation by upregulating GRPEL1, an MPQC component.
- Targeting the c-Myc/GRPEL1 axis inhibits fatty acid synthesis and PDAC tumor growth.
- c-Myc, GRPEL1, and FASN are overexpressed in PDAC tissues and correlated with each other.

## Abstract

Pancreatic ductal adenocarcinoma (PDAC) cells undergo mitochondrial metabolic reprogramming to support their proliferation. However, the mechanisms by which mitochondrial protein quality control (MPQC) regulates cell metabolism remain unclear. Here, we found that c-Myc promotes PDAC cell proliferation by transcriptionally upregulating the expression of GRPEL1, an essential MPQC component. Mechanistically, c-Myc-regulated GRPEL1 maintains oxidative phosphorylation (OXPHOS) and minimizes ROS accumulation, thereby facilitating de novo fatty acid (FA) synthesis through the transcriptional upregulation of fatty acid synthase (FASN) expression. Targeting the c-Myc/GRPEL1 axis to block FASN-regulated FA synthesis inhibited PDAC cell proliferation and tumor growth in both cell models and patient-derived organoids (PDOs), whereas FA supplementation partially reversed this inhibitory effect. Clinically, c-Myc expression is positively associated with the levels of MPQC components in pancreatic ductal cells, with GRPEL1 ranking among the top hits. Furthermore, c-Myc, GRPEL1, and FASN are all expressed at higher levels in PDAC tissues than in peri-tumoral pancreatic tissues, and both c-Myc and GRPEL1 expression levels are positively correlated with that of FASN. These findings suggest that therapeutic inhibition of FA synthesis may be promising for treating PDAC patients with active c-Myc/GRPEL1/FASN signaling. Overall, this study demonstrates that FA synthesis mediated by the c-Myc/GRPEL1/FASN axis is essential for PDAC growth.

## Linked entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], GRPEL1 (GrpE like 1, mitochondrial) [NCBI Gene 80273], FASN (fatty acid synthase) [NCBI Gene 2194]
- **Diseases:** pancreatic ductal adenocarcinoma (MONDO:0005184)

## Full-text entities

- **Genes:** GRPEL1 (GrpE like 1, mitochondrial) [NCBI Gene 80273] {aka GrpE, HMGE, mt-GrpE#1}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}
- **Diseases:** PDAC (MESH:D021441), tumor (MESH:D009369)
- **Chemicals:** ROS (-), FA (MESH:D005227)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12894993/full.md

---
Source: https://tomesphere.com/paper/PMC12894993